These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23645684)

  • 21. Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness.
    Brookes DW; Miah S; Lackenby A; Hartgroves L; Barclay WS
    J Antimicrob Chemother; 2011 Mar; 66(3):466-70. PubMed ID: 21172786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of replication-competent recombinant influenza A viruses carrying a reporter gene harbored in the neuraminidase segment.
    Li F; Feng L; Pan W; Dong Z; Li C; Sun C; Chen L
    J Virol; 2010 Nov; 84(22):12075-81. PubMed ID: 20826692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus.
    Pokorná J; Pachl P; Karlukova E; Hejdánek J; Řezáčová P; Machara A; Hudlický J; Konvalinka J; Kožíšek M
    Viruses; 2018 Jun; 10(7):. PubMed ID: 29933553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of critical residues in the hemagglutinin and neuraminidase of influenza virus H1N1pdm for vaccine virus replication in embryonated chicken eggs.
    Wang W; Lu J; Cotter CR; Wen K; Jin H; Chen Z
    J Virol; 2013 Apr; 87(8):4642-9. PubMed ID: 23408613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.
    Tai CY; Escarpe PA; Sidwell RW; Williams MA; Lew W; Wu H; Kim CU; Mendel DB
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3234-41. PubMed ID: 9835519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains.
    Doyle TM; Li C; Bucher DJ; Hashem AM; Van Domselaar G; Wang J; Farnsworth A; She YM; Cyr T; He R; Brown EG; Hurt AC; Li X
    Biochem Biophys Res Commun; 2013 Nov; 441(1):226-9. PubMed ID: 24140051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of critical contact residues in the NC41 epitope of a subtype N9 influenza virus neuraminidase.
    Nuss JM; Whitaker PB; Air GM
    Proteins; 1993 Feb; 15(2):121-32. PubMed ID: 7680132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
    Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
    J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional and structural analysis of influenza virus neuraminidase N3 offers further insight into the mechanisms of oseltamivir resistance.
    Li Q; Qi J; Wu Y; Kiyota H; Tanaka K; Suhara Y; Ohrui H; Suzuki Y; Vavricka CJ; Gao GF
    J Virol; 2013 Sep; 87(18):10016-24. PubMed ID: 23824808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using common spatial distributions of atoms to relate functionally divergent influenza virus N10 and N11 protein structures to functionally characterized neuraminidase structures, toxin cell entry domains, and non-influenza virus cell entry domains.
    Weininger A; Weininger S
    PLoS One; 2015; 10(2):e0117499. PubMed ID: 25706124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic analysis reveals that both haemagglutinin and neuraminidase determine the sensitivity of naturally occurring avian influenza viruses to zanamivir in vitro.
    Baigent SJ; Bethell RC; McCauley JW
    Virology; 1999 Oct; 263(2):323-38. PubMed ID: 10544106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
    Ives JA; Carr JA; Mendel DB; Tai CY; Lambkin R; Kelly L; Oxford JS; Hayden FG; Roberts NA
    Antiviral Res; 2002 Aug; 55(2):307-17. PubMed ID: 12103431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single PA mutation as a high yield determinant of avian influenza vaccines.
    Lee I; Il Kim J; Park S; Bae JY; Yoo K; Yun SH; Lee JY; Kim K; Kang C; Park MS
    Sci Rep; 2017 Jan; 7():40675. PubMed ID: 28084423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining crystallographic information and an aspherical-atom data bank in the evaluation of the electrostatic interaction energy in an enzyme-substrate complex: influenza neuraminidase inhibition.
    Dominiak PM; Volkov A; Dominiak AP; Jarzembska KN; Coppens P
    Acta Crystallogr D Biol Crystallogr; 2009 May; 65(Pt 5):485-99. PubMed ID: 19390154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
    Kwon JJ; Choi WS; Jeong JH; Kim EH; Lee OJ; Yoon SW; Hwang J; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Gen Virol; 2018 Mar; 99(3):292-302. PubMed ID: 29493493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation-induced loop opening and energetics for binding of tamiflu to influenza N8 neuraminidase.
    Kar P; Knecht V
    J Phys Chem B; 2012 May; 116(21):6137-49. PubMed ID: 22553951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.
    Prachanronarong KL; Canale AS; Liu P; Somasundaran M; Hou S; Poh YP; Han T; Zhu Q; Renzette N; Zeldovich KB; Kowalik TF; Kurt-Yilmaz N; Jensen JD; Bolon DNA; Marasco WA; Finberg RW; Schiffer CA; Wang JP
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30381484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Key amino acid residues of neuraminidase involved in influenza A virus entry.
    Chen F; Liu T; Xu J; Huang Y; Liu S; Yang J
    Pathog Dis; 2019 Aug; 77(6):. PubMed ID: 31702775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain.
    Hussain Basha S; Prasad RN
    BMC Res Notes; 2012 Feb; 5():105. PubMed ID: 22340192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of antigenic variation in an individual epitope on influenza virus N9 neuraminidase.
    Air GM; Laver WG; Webster RG
    J Virol; 1990 Dec; 64(12):5797-803. PubMed ID: 1700825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.